News | Cardiac Rehabilitation | February 09, 2022

Study Identifies VE-cadherin Protein as Key Factor in Maintenance of Lymphatic Vessels Serving the Heart

Scientists revealed how the protein VE-cadherin is a key player in the maintenance and function of lymphatic vessels in the heart, but that loss of these vessels is not associated with decreased heart function after heart attack.

Lymphatic vessels on the heart

February 9, 2022 – Scientists at the UNC School of Medicine led a study to advance the understanding of lymphatic vessels, which transport lymph, a clear fluid containing important molecules, immune cells and fluid, away from organs and tissues and back to the bloodstream. Although anatomists first described the lymphatic system centuries ago, scientists only recently developed the tools to tease apart its distinct and specialized roles in different organs.

In this study, published in Circulation Research, UNC School of Medicine researchers identified a protein called VE-cadherin as a key factor in the maintenance of lymphatic vessels serving the heart. Deleting VE-cadherin from the lymphatic vessels in newborn and adult lab mice caused the lymphatic vessels in the heart to regress and eventually disappear. They also found that these vessels were not functioning properly. Interestingly, loss of the cardiac lymphatic vessels was not associated with a worsened impairment of heart function, even after an experimentally induced heart attack.

“Everyone had assumed that cardiac lymphatic vessels would be critical for preventing the abnormal buildup of fluid in the heart after injury, but our work suggests that might not be the case,” said study senior author Kathleen Caron, PhD, professor and chair of the UNC Department of Cell Biology and Physiology. “Our work also underscores the fact that lymphatic vessels tend to have very specialized functions in different parts of the body.”

The scientists used a line of mice engineered so the gene for VE-cadherin can be selectively deleted from lymphatic cells at a chosen time. Prior studies found that loss of VE-cadherin has profound and diverse effects on the lymphatic vessels found in different organs, such as the gut and skin. However, the specific effects of VE-cadherin loss in lymphatic vessels in the heart had not been described.

In experiments led by UNC-Chapel Hill graduate students Natalie Harris and Natalie Nielsen, the researchers found that deleting the VE-cadherin gene in newborn mice, or even in adult mice, caused severe regression of cardiac lymphatic vessels. This was a striking observation on its own and demonstrated the importance of VE-cadherin in the maintenance of cardiac lymphatics. The researchers also identified some of the key molecular signaling pathways through which VE-cadherin exerts this maintenance effect.

But the researchers also used these cardiac-lymphatic-deficient mice as a new kind of model for studying the role of cardiac lymphatics in normal heart function and heart repair after injury. The findings here were quite unexpected.

Compared to the hearts of mice with normal cardiac lymphatics, the hearts with almost-no-lymphatics appeared to beat and pump blood normally.  They did not accumulate fluid and swell up, as often happens to tissues in the body when local lymphatics are disrupted. This was surprising, given that the researchers demonstrated that these VE-cadherin deficient cardiac lymphatics were not functioning normally at baseline. Following an experimentally induced heart attack, the lymphatic-deficient hearts did not function any worse than did hearts with normal lymphatics.

Scientists who study the heart had widely assumed that cardiac lymphatics have important supporting roles in ordinary heart function but also in repair after injury.  Numerous prior studies demonstrated that experimentally increasing the growth of cardiac lymphatics after a heart attack improves heart function.  It was assumed that this effect was due to a prevention of fluid buildup and swelling, also called edema.

“This interesting mouse model tells us that preventing cardiac edema may not be the primary function of cardiac lymphatic vessels after injury,” said Caron, who is also a member of the UNC McAllister Heart Institute.

Based on their new findings, Caron and colleagues plan to explore whether lymphatic vessels perform other important functions in supporting the heart. For example, the lymphatic system, which includes lymph nodes connected together by a superhighway of lymphatic vessels, helps the immune system detect infections and injuries, mobilize proper responses, and traffic immune cells to and from tissues during the injury and repair process. Caron’s lab is now investigating these potential immune-related functions in heart lymphatic vessels.

The paper titled, “VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling” was co-authored by Natalie Harris, Natalie Nielsen, John Pawlak, Amir Aghajanian, Krsna Rangarajan, D. Stephen Serafin, Gregory Farber, Danielle Dy, Nathan Nelson-Maney, Wenjing Xu, Disha Ratra, Sophia Hurr, Li Qian, and Joshua Scallan.

The study was supported by grants from the National Institutes of Health (HL1290986, DK119145, T32HL069768, F31 HL143836, T32CA071341, T32GM133364-01A1, R35HL155656, RO1 HL142905) and from the American Heart Association.

For more information:

Related Content

News | Cardiac Rehabilitation

February 2, 2023 — In a newly published paper, a team including two professors from Illinois Institute of Technology ...

Home February 02, 2023
News | Cardiac Rehabilitation
May 2, 2022 – A method for delivering genetic material to the body is being tested as a way to repair damaged heart ...
Home May 02, 2022
News | Cardiac Rehabilitation

September 14, 2021 – MedAxiom, an American College of Cardiology (ACC) company, released a report detailing cardiac ...

Home September 14, 2021
News | Cardiac Rehabilitation

January 15, 2020 – Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a heart ...

Home January 15, 2020
Technology | Cardiac Rehabilitation

July 23, 2018 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PocketECG Cardiac ...

Home July 24, 2018
News | Cardiac Rehabilitation

November 15, 2016 — Depression has been known to be associated with poor cardiovascular outcomes. But if patients who ...

Home November 15, 2016
Feature | Cardiac Rehabilitation | Karen D. Walker, RN, MSN, and Stephanie Rejc, MS

Cardiac rehabilitation and exercise training has been shown to improve clinical status and outcomes in congestive heart ...

Home May 24, 2016
News | Cardiac Rehabilitation

March 31, 2016 — New research finds that adding a digital health tool to traditional cardiac rehabilitation appears to ...

Home March 31, 2016
Feature | Cardiac Rehabilitation

July 17, 2015 - Hospitals in the Midwest were more likely than others to refer patients for guideline-recommended ...

Home July 17, 2015
Subscribe Now